Sanofi (SNYNF) EBITDA Margin (2009 - 2026)

Sanofi (SNYNF) posted EBITDA Margin of 117.03% for Q1 2026, up 187.29% sequentially from 134.08% in Q4 2025, and down 274.0% YoY from 67.26% in Q1 2025.

Sanofi (SNYNF) EBITDA Margin (2009 - 2026) Analysis & Trends

Sanofi (SNYNF) has 18 years of EBITDA Margin data on file, last reported at 117.03% in Q1 2026.

  • Quarterly EBITDA Margin fell 274.0% year-over-year to 117.03% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 167.87% (up 956.0% YoY) and the FY2025 annual result came in at 14.54%, down 311.0% from the prior year.
  • EBITDA Margin rose to 117.03% in Q1 2026 per SNYNF's latest filing, from 134.08% in the prior quarter.
  • The five-year high for EBITDA Margin was 362.65% in Q4 2024, with the low at 134.08% in Q4 2025.
  • Average EBITDA Margin over 5 years is 120.06%, with a median of 119.29% recorded in 2023.
  • Year-over-year, EBITDA Margin soared 24963 bps in 2024 and tumbled 49673 bps in 2025.
  • Sanofi's EBITDA Margin stood at 163.1% in 2022, then sank by 31 bps to 113.02% in 2023, then surged by 221 bps to 362.65% in 2024, then plunged by 137 bps to 134.08% in 2025, then jumped by 187 bps to 117.03% in 2026.
  • Business Quant data shows SNYNF's EBITDA Margin at 117.03% in Q1 2026, 134.08% in Q4 2025, and 118.08% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 47.98%
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 26.44%
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 26.60%
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn 18.85%
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -47.46%
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 30.94%
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 37.16%
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -286.83%
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Sanofi - - 9.49 Bn 117.03%

Historic Data

Download Data
DateValue
Mar 31, 2026 117.03%
Dec 31, 2025 -134.08%
Sep 30, 2025 118.08%
Jun 30, 2025 122.68%
Mar 31, 2025 119.78%
Dec 31, 2024 362.65%
Sep 30, 2024 110.98%
Jun 30, 2024 121.66%
Mar 31, 2024 124.84%
Dec 31, 2023 113.02%
Sep 30, 2023 111.65%
Jun 30, 2023 119.68%
Mar 31, 2023 119.29%
Dec 31, 2022 188.41%
Sep 30, 2022 112.65%
Jun 30, 2022 121.99%
Mar 31, 2022 115.94%
Dec 31, 2021 225.27%
Sep 30, 2021 110.00%
Jun 30, 2021 115.59%